PT Asset Management’s Celgene Corp CELG Stock Holding History

PT Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,800	Closed	-$195K	–	253
2016 Q2	$178K	Buy	+1,800	New	+$186K	0.03%	209

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PT Asset Management's CELG Position: Q3 2016 in Review

PT Asset Management sold out of Celgene Corp (CELG) in Q3 2016, closing a stake of 1,800 shares — an estimated $195K sold.

PT Asset Management first reported a position in CELG in Q2 2016 and held it in 1 quarter. The position peaked at $178K in Q2 2016. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

PT Asset Management reported no remaining Celgene Corp position as of Q3 2016 after selling out during the quarter.
PT Asset Management sold 1,800 Celgene Corp shares in Q3 2016, an estimated $195K.
PT Asset Management first reported a position in Celgene Corp in Q2 2016 and held it in 1 quarter.
PT Asset Management's Celgene Corp position peaked at $178K in Q2 2016.
1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on PT Asset Management's 13F filing for Q3 2016, filed 10 Nov 2016.